Results 1 to 10 of about 24,130 (177)
A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and Colombia [PDF]
PLoS Neglected Tropical Diseases, 2015 BACKGROUND:The rise in dengue fever cases and the absence of dengue vaccines will likely cause governments to consider various types of effective means for controlling the disease.
Thiem Vu +2 more
exaly +2 more sources
Vaccines licensed and in clinical trials for the prevention of dengue
Human Vaccines and Immunotherapeutics, 2017 Dengue has become a major global public health threat with almost half of the world's population living in at-risk areas. Vaccination would likely represent an effective strategy for the management of dengue disease in endemic regions, however to date ...
J. Torresi, G. Ebert, M. Pellegrini
exaly +2 more sources
Tracing down the Updates on Dengue Virus—Molecular Biology, Antivirals, and Vaccine Strategies
Vaccines, 2023 Background: Nearly half of the world is at risk of developing dengue infection. Dengue virus is the causative agent behind this public healthcare concern. Millions of dengue cases are reported every year, leading to thousands of deaths.
Shiza Malik +5 more
doaj +1 more source
Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?
Frontiers in Medical Technology, 2021 Dengue infections still have a tremendous impact on public health systems in most countries in tropical and subtropical regions. The disease is systemic and dynamic with broad range of manifestations, varying from mild symptoms to severe dengue (Dengue ...
Ada Maria Barcelos Alves +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 In 2019, Bangladesh has grappled with a record-breaking surge in dengue fever, experiencing the highest number of dengue cases since the year 2000. Together, the intensification of dengue fever combined with a lack of dengue vaccines and appropriate ...
K M Ariful Kabir +2 more
doaj +1 more source
Vaccine development for mosquito-borne viral diseases
Frontiers in Immunology, 2023 Mosquito-borne viral diseases are a group of viral illnesses that are predominantly transmitted by mosquitoes, including viruses from the Togaviridae and Flaviviridae families.
Zhiwei Huang +7 more
doaj +1 more source
Frontiers in Immunology, 2021 The four serotypes of Dengue virus (DENV1-4) are arboviruses (arthropod-borne viruses) that belong to the Flavivirus genus, Flaviviridae family. They are the causative agents of an infectious disease called dengue, an important global public health ...
Josilene Ramos Pinheiro +13 more
doaj +1 more source
Efficacy of Live Attenuated Dengue Vaccines: CYD-TDV, TDV (TAK-003), and TV003/TV005
Folia Medica Indonesiana, 2021 Highlight: • Differences in the efficacy of CYD-TDV versus the other TAK-003 and TV003/TV005 were discussed. • One licensed dengue vaccine is CYD-TDV (Dengvaxia).
Yoseph Jeffry Hertanto +1 more
doaj +1 more source
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development
Viruses, 2011 Dengue has become the most important arboviral infection worldwide with more than 30 million cases of dengue fever estimated to occur each year. The need for a dengue vaccine is great and several live attenuated dengue candidate vaccines are proceeding ...
Anna P. Durbin, Stephen S. Whitehead
doaj +1 more source
Vaccines and immunization strategies for dengue prevention
Emerging Microbes and Infections, 2016 Dengue is currently the most significant arboviral disease afflicting tropical and sub-tropical countries worldwide. Dengue vaccines, such as the multivalent attenuated, chimeric, DNA and inactivated vaccines, have been developed to prevent dengue ...
Yang Liu, Jianying Liu, Gong Cheng
doaj +1 more source